BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30582832)

  • 1. ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China.
    Li X; Xu H; Gao P
    Med Sci Monit; 2018 Dec; 24():9392-9398. PubMed ID: 30582832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
    Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
    Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.
    Egawa N; Lin Y; Tabata T; Kuruma S; Hara S; Kubota K; Kamisawa T
    World J Gastroenterol; 2013 Apr; 19(16):2537-42. PubMed ID: 23674856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood group and the risk of pancreatic cancer.
    Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
    J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.
    Ben Q; Cai Q; Li Z; Yuan Y; Ning X; Deng S; Wang K
    Eur J Cancer; 2011 Jan; 47(2):248-54. PubMed ID: 20709528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study.
    Woo SM; Joo J; Lee WJ; Park SJ; Han SS; Kim TH; Koh YH; Kim HB; Hong EK
    J Korean Med Sci; 2013 Feb; 28(2):247-51. PubMed ID: 23400555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.
    Gong Y; Yang YS; Zhang XM; Su M; Wang J; Han JD; Guo MZ
    World J Gastroenterol; 2012 Feb; 18(6):563-9. PubMed ID: 22363124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan.
    Tseng CM; Liao WC; Chang CY; Lee CT; Tseng CH; Hsu YC; Lin JT
    Pancreatology; 2017; 17(1):76-82. PubMed ID: 27743712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Heart Disease and ABO Blood Group in Diabetic Women: A Case-Control Study.
    Langari SH; Bahar A; Asadian L; Abediankenai S; Namazi SS; Kashi Z
    Sci Rep; 2019 May; 9(1):7441. PubMed ID: 31092877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
    Zhou Y; Zhou Q; Lin Q; Chen R; Gong Y; Liu Y; Yu M; Zeng B; Li K; Chen R; Li Z
    Int J Cancer; 2013 Oct; 133(8):1867-75. PubMed ID: 23564396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.
    Ben Q; Li Z; Liu C; Cai Q; Yuan Y; Wang K; Xiao L; Gao J; Zhang H
    Pancreas; 2012 Apr; 41(3):435-40. PubMed ID: 22422136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of acute epiglottitis in patients with preexisting diabetes mellitus: A population-based case-control study.
    Tsai YT; Huang EI; Chang GH; Tsai MS; Hsu CM; Yang YH; Lin MH; Liu CY; Li HY
    PLoS One; 2018; 13(6):e0199036. PubMed ID: 29889887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.
    Antwi SO; Bamlet WR; Pedersen KS; Chaffee KG; Risch HA; Shivappa N; Steck SE; Anderson KE; Bracci PM; Polesel J; Serraino D; La Vecchia C; Bosetti C; Li D; Oberg AL; Arslan AA; Albanes D; Duell EJ; Huybrechts I; Amundadottir LT; Hoover R; Mannisto S; Chanock SJ; Zheng W; Shu XO; Stepien M; Canzian F; Bueno-de-Mesquita B; Quirós JR; Zeleniuch-Jacquotte A; Bruinsma F; Milne RL; Giles GG; Hébert JR; Stolzenberg-Solomon RZ; Petersen GM
    Carcinogenesis; 2018 Jul; 39(8):1056-1067. PubMed ID: 29800239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of ABO and Rhesus blood groups with the occurrence of type 2 diabetes mellitus: A comparative cross-sectional study.
    Walle M; Tesfaye A; Getu F
    Medicine (Baltimore); 2023 Sep; 102(35):e34803. PubMed ID: 37657021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two different types of diabetes mellitus in pancreatic cancer population. Comparative study between new onset and long standing diabetes mellitus on 76 patients with pancreatic cancer.
    Tanţău A; Negrean V; Alexescu T; Para I; Tărmure S; Casoinic F; Sâmpelean D; Mocanu T; Tanţău M
    Rom J Intern Med; 2014; 52(1):18-23. PubMed ID: 25000673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
    Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
    Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.
    Brodovicz KG; Kou TD; Alexander CM; O'Neill EA; Engel SS; Girman CJ; Goldstein BJ
    Diabetes Obes Metab; 2012 Dec; 14(12):1123-8. PubMed ID: 22831166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study.
    Ben Q; Wang K; Yuan Y; Li Z
    Int J Cancer; 2011 Mar; 128(5):1179-86. PubMed ID: 20473916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO blood group and esophageal carcinoma risk: from a case-control study in Chinese population to meta-analysis.
    Wang W; Liu L; Wang Z; Lu X; Wei M; Lin T; Zhang Y; Jiang S; Wang Q; Cao Z; Shi M
    Cancer Causes Control; 2014 Oct; 25(10):1369-77. PubMed ID: 25064033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
    Li D; Pise MN; Overman MJ; Liu C; Tang H; Vadhan-Raj S; Abbruzzese JL
    Cancer Med; 2015 Nov; 4(11):1651-8. PubMed ID: 26275671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.